Latest Side Effects news
Study Compares Short-Term Use of Cannabinoid Products for Chronic Pain
posted January 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
GI Safety Profile Similar for Dulaglutide, Semaglutide, Tirzepatide
posted November 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Sends 100 Cease-and-Desist Letters in Crackdown on DTC Drug Advertisements
posted September 12th
by modernClinician Editorial Team
by modernClinician Editorial Team
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
posted May 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy .jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
GLP-1 Receptor Agonists Tied to Increased Risk for Alopecia .jpg)
Health Consequences Vary by Chemo Regimen in Testicular Cancer Survivors 
Satisfaction With Semaglutide Driven by Effective Weight Loss Monthly Specialist Briefings
Stay Connected
